ATE372119T1 - Verfahren zur behandlung von bakteriellen infektionen mit gemifloxacin oder einem seiner salze und einem beta-lactam-antibiotikum - Google Patents
Verfahren zur behandlung von bakteriellen infektionen mit gemifloxacin oder einem seiner salze und einem beta-lactam-antibiotikumInfo
- Publication number
- ATE372119T1 ATE372119T1 AT02795444T AT02795444T ATE372119T1 AT E372119 T1 ATE372119 T1 AT E372119T1 AT 02795444 T AT02795444 T AT 02795444T AT 02795444 T AT02795444 T AT 02795444T AT E372119 T1 ATE372119 T1 AT E372119T1
- Authority
- AT
- Austria
- Prior art keywords
- gemifloxacin
- beta
- bacterial infections
- lactam antibiotic
- salts
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
- A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/407—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/4375—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having nitrogen as a ring heteroatom, e.g. quinolizines, naphthyridines, berberine, vincamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
- A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
- A61K31/546—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine containing further heterocyclic rings, e.g. cephalothin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US33449501P | 2001-11-30 | 2001-11-30 |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE372119T1 true ATE372119T1 (de) | 2007-09-15 |
Family
ID=23307473
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT02795444T ATE372119T1 (de) | 2001-11-30 | 2002-11-29 | Verfahren zur behandlung von bakteriellen infektionen mit gemifloxacin oder einem seiner salze und einem beta-lactam-antibiotikum |
Country Status (13)
Country | Link |
---|---|
US (1) | US7169792B2 (de) |
EP (1) | EP1458391B1 (de) |
AT (1) | ATE372119T1 (de) |
AU (1) | AU2002360218A1 (de) |
CA (1) | CA2468036C (de) |
CY (1) | CY1107038T1 (de) |
DE (1) | DE60222298T2 (de) |
DK (1) | DK1458391T3 (de) |
ES (1) | ES2292844T3 (de) |
MX (1) | MXPA04005179A (de) |
NO (1) | NO333196B1 (de) |
PT (1) | PT1458391E (de) |
WO (1) | WO2003045390A1 (de) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ITMI20080289A1 (it) * | 2008-02-22 | 2009-08-23 | S I F I Societa Industria Farmaceutica Italia | Composizioni di gemifloxacina con elevata efficacia su patologie oculari |
EP2143422A1 (de) * | 2008-07-11 | 2010-01-13 | S.I.F.I - Società Industria Farmaceutica Italiana - S.P.A. | Ophthalmische Zusammensetzungen enthaltend Gemifloxacin zur Behandlung von Augeninfektionen |
EP2536408A1 (de) * | 2010-02-16 | 2012-12-26 | Wockhardt Research Centre | Effluxpumpenhemmer |
ES2568647T3 (es) * | 2010-02-25 | 2016-05-03 | Santen Pharmaceutical Co., Ltd | Gotas oftálmicas para tratar infección ocular que contienen levofloxacino, sal del mismo o solvato del mismo, método de tratamiento de infección ocular, levofloxacino, sal del mismo o solvato del mismo, y su uso |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3711343A1 (de) * | 1987-04-03 | 1988-10-20 | Bayer Ag | Cephalosporinderivate, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln |
MA24500A1 (fr) * | 1997-03-21 | 1998-10-01 | Lg Life Sciences Ltd | Derive du sel d'acide carboxylique de naphthyridine . |
US6576224B1 (en) * | 1999-07-06 | 2003-06-10 | Sinuspharma, Inc. | Aerosolized anti-infectives, anti-inflammatories, and decongestants for the treatment of sinusitis |
-
2002
- 2002-11-29 MX MXPA04005179A patent/MXPA04005179A/es active IP Right Grant
- 2002-11-29 EP EP02795444A patent/EP1458391B1/de not_active Expired - Lifetime
- 2002-11-29 DE DE60222298T patent/DE60222298T2/de not_active Expired - Lifetime
- 2002-11-29 CA CA002468036A patent/CA2468036C/en not_active Expired - Lifetime
- 2002-11-29 PT PT02795444T patent/PT1458391E/pt unknown
- 2002-11-29 ES ES02795444T patent/ES2292844T3/es not_active Expired - Lifetime
- 2002-11-29 WO PCT/KR2002/002248 patent/WO2003045390A1/en active IP Right Grant
- 2002-11-29 AT AT02795444T patent/ATE372119T1/de active
- 2002-11-29 AU AU2002360218A patent/AU2002360218A1/en not_active Abandoned
- 2002-11-29 DK DK02795444T patent/DK1458391T3/da active
- 2002-11-29 US US10/496,809 patent/US7169792B2/en not_active Expired - Lifetime
-
2004
- 2004-06-28 NO NO20042711A patent/NO333196B1/no not_active IP Right Cessation
-
2007
- 2007-11-28 CY CY20071101521T patent/CY1107038T1/el unknown
Also Published As
Publication number | Publication date |
---|---|
EP1458391B1 (de) | 2007-09-05 |
DE60222298D1 (de) | 2007-10-18 |
MXPA04005179A (es) | 2004-08-11 |
EP1458391A4 (de) | 2005-05-11 |
NO20042711L (no) | 2004-06-30 |
EP1458391A1 (de) | 2004-09-22 |
CY1107038T1 (el) | 2012-09-26 |
CA2468036A1 (en) | 2003-06-05 |
DK1458391T3 (da) | 2008-01-07 |
PT1458391E (pt) | 2007-12-10 |
US20050148571A1 (en) | 2005-07-07 |
ES2292844T3 (es) | 2008-03-16 |
CA2468036C (en) | 2008-01-22 |
NO333196B1 (no) | 2013-04-02 |
DE60222298T2 (de) | 2008-01-03 |
WO2003045390A1 (en) | 2003-06-05 |
AU2002360218A1 (en) | 2003-06-10 |
US7169792B2 (en) | 2007-01-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PT759774E (pt) | Metodo para o tratamento de infeccoes bacterianas gram-negativas por administracao de um produto de proteina bactericida indutora da permeabilidade (bip) e de um antibiotico | |
ATE347277T1 (de) | Zusammensetzung mit bakteriostatischen und bakteriziden eigenschaften gegen bakterielle sporen und zellen und verfahren zu deren verwendung zur behandlung von lebensmitteln | |
DE60326273D1 (de) | Verfahren und verbindungen zur verstärkung der fybrozyten-bildung | |
CY1108437T1 (el) | Φαρμακοτεχνικες μορφες οι οποιες περιεχουν μια ενωση κεφαλοσπορινης και η χρηση τους στη θεραπεια βακτηριακων λοιμωξεων σε γατους και σκυλους | |
ATE427116T1 (de) | Behandlung von bakteriellen infektionen | |
MXPA02001254A (es) | Formulacion de moxifloxacino con sal-comun. | |
ATE354363T1 (de) | Kombination von drei substanzen zur vorbeugung und behandlung von arthritis | |
DE60310400D1 (de) | Botulinustoxine zur behandlung von priapismus | |
DE60219658D1 (de) | Verfahren zur prävention und behandlung von infektionen mit dem flavivirus bei tieren | |
WO2005039494A3 (en) | Inhibitors of rnase p proteins as antibacterial compounds | |
CY1107038T1 (el) | Μεθοδος θεραπειας βακτηριακων λοιμωξεων με χρηση της γεμιφλοξασινης ή ενος αλατος αυτης και ενος αντιβιοτικου β-λακταμης | |
DE60112581D1 (de) | Zusammensetzungen zur behandlung baktrieller infektionen, welche ein oxazolidinonderivat, sulbactam und ampicillin enthalten | |
ATE358419T1 (de) | Neue substituierte bernsteinsäure metall-beta- lactamase-inhibitoren und ihre verwendung zur behandlung von bakteriellen infektionen | |
DE60131085D1 (de) | Antimikrobielle sulfonamide-derivate von lipopeptidantibiotika | |
DE602004023100D1 (de) | Verbindungen und verfahren zur behandlung von dyslipidemie | |
ATE404197T1 (de) | Verfahren zur behandlung von bakteriellen infektionen mit gemifloxacin oder einem seiner salze und einem antibakteriellen carbapenem- mittel | |
DE602004015307D1 (de) | Verwendung von tigecyclin, allein oder in kombination mit rifampin zur behandlung von osteomyelitis und/oder septischer arthritis | |
DE602004017214D1 (de) | Antibakterielle und/oder gegen protozoen wirksame nitroimidazolderivatverbindungen mit ureasehemmender wirkung, verfahren zur herstellung dieser verbindungen und deren verwendung in pharmazeutischen zusammensetzungen und medikamenten | |
DE60137459D1 (de) | Verfahren und zusammensetzungen zur behandlung oder prävention von bakteriellen infektionen | |
DE69906701D1 (de) | Topische verwendung von loperamid zur behandlung mikrobieller infektionen | |
DE60233353D1 (de) | Verfahren zur behandlung von halitose | |
MX9304266A (es) | Quinolinas y naftiridinas de 3-carboxaldehido sustituidas. | |
DE60137506D1 (de) | Verwendung von polysulfatierten cyclodextrinen zur behandlung von arthrose | |
DE69906729D1 (de) | Zusammensetzung und methode zur behandlung von pseudomonas aeruginosa infektionen | |
WO2003101393A3 (en) | Antibacterial compounds and methods for treating gram positive bacterial infections |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification |
Ref document number: 1458391 Country of ref document: EP |